Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
34.01
+0.71 (2.13%)
At close: Jun 26, 2026, 4:00 PM EDT
33.99
-0.02 (-0.06%)
After-hours: Jun 26, 2026, 5:45 PM EDT
Pharvaris Employees
Pharvaris had 134 employees as of March 31, 2026. The number of employees increased by 5 or 3.88% since the number was last reported on December 31, 2025.
Employees
134
Change
5
Growth
3.88%
Revenue / Employee
n/a
Profits / Employee
-$1,450,369
Market Cap
2.38B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Agios Pharmaceuticals | 540 |
| Vericel | 398 |
| Intellia Therapeutics | 377 |
| Ocular Therapeutix | 325 |
| Nurix Therapeutics | 317 |
| Biohaven | 274 |
| Immunome | 206 |
| Kodiak Sciences | 130 |
PHVS News
- 2 days ago - Pharvaris price target raised to $46 from $41 at Morgan Stanley - TheFly
- 12 days ago - Data Supporting Differentiated Profile of Deucrictibant in HAE Management Presented at EAACI 2026 - GlobeNewsWire
- 16 days ago - Pharvaris Announces Annual General Meeting of Shareholders - GlobeNewsWire
- 23 days ago - Pharvaris management to meet with Oppenheimer - TheFly
- 4 weeks ago - Pharvaris management to meet with Oppenheimer - TheFly
- 4 weeks ago - Pharvaris to Present Clinical Data at the EAACI Annual Congress 2026 - GlobeNewsWire
- 5 weeks ago - Pharvaris Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Pharvaris price target raised to $33 from $31 at BofA - TheFly